Lifecitam 500 Tablet contains Levetiracetam 500 mg, an antiepileptic medication indicated for the treatment of partial-onset seizures, myoclonic seizures, and primary generalized tonic-clonic seizures in adults and pediatric patients. Levetiracetam acts by modulating synaptic neurotransmitter release through binding to the synaptic vesicle protein SV2A, which is believed to inhibit burst firing and reduce seizure propagation. Lifecitam 500 is used as monotherapy or adjunctive therapy in epilepsy management. The drug is rapidly absorbed after oral administration, with peak plasma concentrations achieved within one hour, and it is primarily excreted unchanged via the kidneys. Dosage should be individualized based on clinical response and renal function, with careful titration to minimize adverse effects. Common side effects include somnolence, dizziness, headache, and fatigue, while serious adverse reactions may involve behavioral changes, mood alterations, and hypersensitivity reactions. Caution is advised in patients with renal impairment, and dose adjustments are necessary. Lifecitam 500 should be used under strict medical supervision, with regular monitoring to optimize therapeutic outcomes and minimize risks. It is contraindicated in patients with known hypersensitivity to Levetiracetam or any excipients. Patient adherence and communication with healthcare providers are essential for effective seizure control.